CDKN2A and prostate carcinoma: As well, BMI1 protein was expressed at high levels in precancerous lesions of prostate cancer (prostatic intraepithelial neoplasias, PINs) and prostate carcinomas, and accompanied by reductions of p16INK4a and p19ARF/p14ARF [135].